Back to Authors

Gelfand, Amy A.

https://orcid.org/0000-0002-0911-7905

A5076177073 | I180670191

Mayo Clinic

University of California, San Francisco

Citations 18

The Headache Innovation Challenge: An outgrowth of the AHS/NINDS Headache research priorities

Headache: The Journal of Head and Face Pain | September 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/head.70230 | PMID 42706866

International Classification of Headache Disorders 4: Classification committee comments on differentiating primary from secondary headache and recognizing “medication overuse”

Cephalalgia | October 30, 2025 | Volume: 45 | Issue: 10 | Pages: No page available

10.1177/03331024251391371 | PMID 41166141

Treatment of medication‐overuse headache in children and adolescents: A systematic review

Headache: The Journal of Head and Face Pain | May 29, 2025 | Volume: 65 | Issue: 7 | Pages: 1148-1159

10.1111/head.14973 | PMID 40439245

Abstract Objective To examine the effectiveness of treatment strategies for medication‐overuse headache (MOH) in children and adolescents. Background There are no guidelines for the treatment of adult or pediatric patients with MOH. However, research pertaining to MOH in adults is far outpacing research in children and adolescents. Methods A systematic review of evidence on treatment for MOH in children and adolescents was performed via PubMed, Embase, Web of Science, PsycINFO, and Cochrane from database inception to October 2024 for articles with the subject headings and keywords for MOH and pediatric, children, and/or adolescent. Inclusion criteria were: (i) randomized controlled trials and retrospective and prospective observational studies, (ii) children and adolescents aged <18 years with chronic headaches and with medication overuse (MO) or MOH, and (iii) interventions addressing MO or MOH, including pharmacologic and behavioral interventions. At least two independent reviewers screened citations and full‐text articles independently. Results A total of 16 studies (one randomized control trial, six prospective observational studies and nine retrospective observational studies) were identified as meeting final inclusion criteria, resulting in 7978 total participants with a subset of those having MO, MOH or probable MOH. Participants ranged in mean age from 10 to 14.7 years, with 7.1%–46.2% male participants. All the studies recruited patients from an outpatient setting. Interventions used in the studies included withdrawal of the overused acute medication, initiation of preventive medication, patient education, physiotherapy and psychological treatment, and motivational interviewing. Multimodal therapy was studied more than single therapeutic intervention. There was vast heterogeneity across the studies, including study design, diagnostic criteria, intervention type, and outcomes. Conclusion From the data available, there does not seem to be a singular superior treatment approach. Accordingly, the most appropriate treatment modality will need to be tailored to the patient and their caregivers. Further research is required regarding management of MOH in children and adolescents.
International Classification of Headache Disorders-4 – Work in progress 2

Cephalalgia | April 16, 2025 | Volume: 45 | Issue: 4 | Pages: No page available

10.1177/03331024251325550 | PMID 40239022

The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group

Headache: The Journal of Head and Face Pain | August 16, 2024 | Volume: 64 | Issue: 8 | Pages: 912-930

10.1111/head.14797 | PMID 39149968

Abstract Objective To identify and disseminate research priorities for the headache field that should be areas of research focus during the next 10 years. Background Establishing research priorities helps focus and synergize the work of headache investigators, allowing them to reach the most important research goals more efficiently and completely. Methods The Headache Research Priorities organizing and executive committees and working group chairs led a multistakeholder and international group of experts to develop headache research priorities. The research priorities were developed and reviewed by clinicians, scientists, people with headache, representatives from headache organizations, health‐care industry representatives, and the public. Priorities were revised and finalized after receiving feedback from members of the research priorities working groups and after a public comment period. Results Twenty‐five research priorities across eight categories were identified: human models, animal models, pathophysiology, diagnosis and management, treatment, inequities and disparities, research workforce development, and quality of life. The priorities address research models and methods, development and optimization of outcome measures and endpoints, pain and non‐pain symptoms of primary and secondary headaches, investigations into mechanisms underlying headache attacks and chronification of headache disorders, treatment optimization, research workforce recruitment, development, expansion, and support, and inequities and disparities in the headache field. The priorities are focused enough that they help to guide headache research and broad enough that they are widely applicable to multiple headache types and various research methods. Conclusions These research priorities serve as guidance for headache investigators when planning their research studies and as benchmarks by which the headache field can measure its progress over time. These priorities will need updating as research goals are met and new priorities arise.
International Classification of Headache Disorders-4 – Work in Progress 1

Cephalalgia | February 22, 2024 | Volume: 44 | Issue: 2 | Pages: No page available

10.1177/03331024241233937 | PMID 38388354

Perspectives of Adolescents/Young Adults on the Burden of Their Parent’s Migraine: Results from the CaMEO Study (P4.121)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p4.121

Benefits and implications of integrating artificial intelligence in manuscripts submitted to Headache

Headache: The Journal of Head and Face Pain | April 27, 2023 | Volume: 63 | Issue: 5 | Pages: 571-572

10.1111/head.14502 | PMID 37102424

Worsening migraine: Another casualty of natural disasters

Headache: The Journal of Head and Face Pain | June 7, 2022 | Volume: 62 | Issue: 6 | Pages: 645-647

10.1111/head.14325 | PMID 35670096

Advancing our commitment to our peer reviewers

Headache: The Journal of Head and Face Pain | October 14, 2021 | Volume: 61 | Issue: 9 | Pages: 1299-1301

10.1111/head.14211